Judy Buelke‐Sam

Development and standardization of screening methods for behavioral teratology

Judy Buelke‐Sam, Carole A. Kimmel · Teratology · 1979 · 53 citations

Diagnosis, Toxicology Testing, Behavioral Screen +23

Communicating risks during pregnancy: A workshop on the use of data from animal developmental toxicity studies in pregnancy labels for drugs

Anthony R. Scialli, Judy Buelke‐Sam, Christina Chambers et al. · Birth Defects Research Part A Clinical and Molecular Teratology · 2004 · 41 citations

Drug Safety, Pregnancy Labels, Early Life Exposure +10

The Selective Estrogen Receptor Modulator, Raloxifene: A Segment II/III Delivery Study in Rats 11This study (except for immune system assessments) was conducted in accordance with the FDA’s Good Laboratory Practices for Nonclinical Laboratory Studies [1].

Judy Buelke‐Sam, Ilene R. Cohen, Daniel Wierda et al. · Reproductive Toxicology · 1998 · 24 citations

Molecular Pharmacology, Immune System Assessments, Medicine +13

The Selective Estrogen Receptor Modulator, Raloxifene: Reproductive Assessments following Premating Exposure in Female Rats 11These studies were conducted in accordance with the Food and Drug Administration “Good Laboratory Practice Regulations for Nonclinical Laboratory Studies.” CRF Part 58, 1978.

J A Hoyt, Lawrence F. Fisher, Judy Buelke‐Sam et al. · Reproductive Toxicology · 1998 · 14 citations

Fertility, Reproductive Health, Female Reproductive Function +20

The Selective Estrogen Receptor Modulator, Raloxifene: Reproductive Assessments Following Preimplantation Exposure in Mated Female Rats 11These studies were conducted in accordance with the Food and Drug Administration “Good Laboratory Practice Regulations for Nonclinical Laboratory Studies.” CRF Part 58, 1978.

David O. Clarke, Kelly I. Griffey, Judy Buelke‐Sam et al. · Reproductive Toxicology · 1998 · 11 citations

Fertility, Female Infertility, Preimplantation Exposure +15